38 reports

It begins in one eye and spreads to the other.

  • Eye Disease
  • Akorn, Inc.
  • Alcon, Inc.
  • Allergan plc
  • Bausch & Lomb Incorporated
  • 3. INTRODUCTION

IT INVOLVES THE DELIVERY OF STEROIDS, MACROMOLECULES, ANTIBIOTICS AND ANTIVIRALS TO OCULAR TISSUES WITH THE AID OF ELECTRIC CURRENT.

  • Eye Disease
  • United States
  • Alcon, Inc.
  • Allergan plc
  • Novartis AG
  • Viral Conjunctivitis - Companies Involved in Therapeutics Development
  • May 13, 2013: Starpharma's Dendrimer SPL7013 Demonstrates Potential As Viral Conjunctivitis Treatment

This is the first clinical study to demonstrate potent antiviral activity of any microbicide beyond one hour after administration of the product in humans.

  • Eye Disease
  • United States
  • World
  • Product Initiative
  • Starpharma Holdings Limited
  • Viral Conjunctivitis - Companies Involved in Therapeutics Development
  • MAY 13, 2013: STARPHARMA'S DENDRIMER SPL7013 DEMONSTRATES POTENTIAL AS VIRAL CONJUNCTIVITIS TREATMENT

This is the first clinical study to demonstrate potent antiviral activity of any microbicide beyond one hour after administration of the product in humans.

  • Eye Disease
  • United States
  • World
  • Product Initiative
  • Starpharma Holdings Limited

About two hundred patient' s were randomly assigned into one of two treatment arms in a ##:## ratio.

  • Eye Disease
  • Ophthalmology
  • United States
  • Product Initiative
  • EyeGate Pharmaceuticals, Inc.
  • SMALL MOLECULE TO INHIBIT NFKB FOR OPHTHALMOLOGY, ONCOLOGY, DERMATOLOGY, IMMUNOLOGY AND INFECTIOUS DISEASE - DRUG PROFILE

About two hundred patients were randomly assigned into one of two treatment arms in a ##:## ratio.

  • Eye Disease
  • Ophthalmology
  • United States
  • Product Initiative
  • EyeGate Pharmaceuticals, Inc.

Teprotumumab (R-##) is an insulin like growth factor ## (IGF-##) receptor antagonist.

  • Eye Disease
  • Therapy
  • United States
  • World
  • Product Initiative
  • PIPELINE BY CHENGDU KANGHONG PHARMACEUTICALS GROUP CO LTD, H2 2018

Chengdu Kanghong Pharmaceuticals offers its products in the form of dispersible tablets, oral drugs, ophthalmic injection, detoxification drugs and antiviral medicines.

  • Eye Disease
  • Ophthalmology
  • United States
  • World
  • Regeneron Pharmaceuticals, Inc.

The company offers products such as anti-fungal, cardiovascular, iron supplements, antibacterial drugs, iron supplements, antiviral medicines, antibody-drug conjugates, veterinary products oncology products, and immunology products.

  • Eye Disease
  • Hospital
  • Protein Therapy
  • Therapy
  • SciFluor Life Sciences, LLC

The company offers products such as anti-fungal, cardiovascular, iron supplements, antibacterial drugs, iron supplements, antiviral medicines, antibody-drug conjugates, veterinary products oncology products, and immunology products.

  • Eye Disease
  • Research And Development
  • United States
  • Product Initiative
  • SciFluor Life Sciences, LLC
  • Graves' Ophthalmopathy - Pipeline by Novartis AG, H2 2017

Teprotumumab (R-##) is insulin like growth factor ## (IGF-##) receptor antagonist.

  • Eye Disease
  • United States
  • World
  • Product Initiative
  • Novartis AG

" We have now seen clinical evidence of antibacterial, antiviral and antifungal activity with product candidates from our nitric oxide platform.

  • Eye Disease
  • Therapy
  • United States
  • World
  • NicOx S.A.
  • PIPELINE BY COHERUS BIOSCIENCES INC, H1 2018

Its products are available in the form of dispersible tablets, oral drugs, ophthalmic injection, detoxification PIPELINE BY BENITEC BIOPHARMA LTD, H## 2018 CHENGDU KANGHONG PHARMACEUTICALS GROUP CO LTD drugs and antiviral medicines, among others.

  • Eye Disease
  • United States
  • World
  • Product Initiative
  • Regeneron Pharmaceuticals, Inc.
  • Z-9445 - DRUG PROFILE

HSV-## LATENT DNA RESULTS IN REACTIVATION OF LATENT HSV-##.

  • Clinical Trial
  • Eye Disease
  • Therapy
  • United States
  • Product Initiative

Partner ## Partner ## Deal status Deal category Deal sub-category Date of announcement COMPANY INFORMATION: PARTNERS Company type PARTNER ##: CHIESI USA, INC.

  • Eye Disease
  • Eyewear
  • United States
  • M&A
  • Bausch & Lomb Incorporated

Chengdu Kanghong Pharmaceuticals offers its products in the form of dispersible tablets, oral drugs, ophthalmic injection, detoxification drugs and antiviral medicines.

  • Eye Disease
  • Ophthalmology
  • Pharmaceutical
  • United States
  • Clearside Biomedical, Inc.
  • Feb 04, 2019: Okogen starts Phase II OKG-0301 trial for adenoviral conjunctivitis

OKG-## is a topical ophthalmic formulation of ranpirnase, a ribonuclease (RNase) that contains broad-spectrum antiviral properties.

  • Eye Disease
  • OTC
  • Therapy
  • World
  • Product Initiative
  • Z-9445 - DRUG PROFILE

NanoViricides' s management will host one-on-one meetings with conference attendees at Biotech Showcase 2016.

  • Eye Disease
  • Therapy
  • United States
  • Product Initiative
  • RegeneRx Biopharmaceuticals, Inc.

Its products are available in the form of dispersible tablets, oral drugs, ophthalmic injection, detoxification drugs and antiviral medicines, among others.

  • Eye Disease
  • Medical Biotechnology
  • Pharmaceutical
  • Therapy
  • United States

Partner ## Partner ## Deal status Deal category Deal sub-category Date of announcement COMPANY INFORMATION: PARTNERS Company type PARTNER ##: CHIESI USA, INC.

  • Eye Disease
  • Eyewear
  • United States
  • M&A
  • Bausch & Lomb Incorporated
  • GEOGRAPHIC ATROPHY - PIPELINE BY ACHILLION PHARMACEUTICALS INC, H2 2018

It is developing oral antiviral therapy for chronic hepatitis C (HCV) and a platform of potent and specific complement inhibitors.

  • Eye Disease
  • Pharmaceutical
  • United States
  • World
  • Product Initiative

## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## P III ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## P II ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## P I ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## IND ## ##

  • Eye Disease
  • Pharmaceutical
  • United States
  • World
  • Product Initiative

Chengdu Kanghong Pharmaceuticals offers its products in the form of dispersible tablets, oral drugs, ophthalmic injection, detoxification drugs and antiviral medicines.

  • Eye Disease
  • Medical Biotechnology
  • United States
  • Company
  • Product Initiative

Risk factors include age and genetic mutations. ##. ## Optic Neuritis - Overview ## Therapeutics Development ##. ## Optic Neuropathy ##. ##. ## PIPELINE OVERVIEW FIGURE ##: NUMBER OF PRODUCTS UNDER DEVELOPMENT FOR OPTIC NEUROPATHY TABLE ##: NUMBER OF PRODUCTS UNDER DEVELOPMENT FOR OPTIC NEUROPAT

  • Eye Disease
  • Ophthalmology
  • Pharmaceutical
  • Type 2 Diabetes
  • Product Initiative
  • ABZENA PLC
  • AGE RELATED MACULAR DEGENERATION - PIPELINE BY ABZENA PLC, H1 2018

It is developing oral antiviral therapy for chronic hepatitis C (HCV) and a platform of potent and specific complement inhibitors.

  • Eye Disease
  • Monoclonal Antibody
  • Ophthalmology
  • Pharmaceutical
  • Allergan plc

HOFFMANN-LA ROCHE LTD KUKJE PHARMACEUTICAL INDUSTRY CO LTD LABORATORIOS SALVAT SA LABORATORIOS SOPHIA SA DE CV MATI THERAPEUTICS INC NEMUS BIOSCIENCE INC NEURIZON PHARMA GBR RADIKAL THERAPEUTICS INC SHIRE PLC SUSTAINED NANO SYSTEMS LLC PC ## ## ## ## ## ## ## ## ## ## ## ## ##

  • Eye Disease
  • Ophthalmology
  • United States
  • Company
  • Product Initiative

Uveitis - Overview Uveitis - Therapeutics Development PIPELINE OVERVIEW NUMBER OF PRODUCTS UNDER DEVELOPMENT FOR UVEITIS, H## 2018 NUMBER OF PRODUCTS UNDER DEVELOPMENT FOR UVEITIS, H## 2018 Pre-Registration ## ## Filing rejected/ Withdrawn ## ## Phase III ## ## Phase II ## ## Phase I ## ## IND/

  • Autoimmune Disease
  • Eye Disease
  • United States
  • Product Initiative
  • Galapagos NV

## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## PR ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## F R/ W ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## Un ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## Total ## ## ## ## ## ## ## ## ## ## ## ## ## ## ## ##

  • Eye Disease
  • Health Services
  • United States
  • Company
  • Product Initiative
  • ICON BIOSCIENCE INC
  • Indication Name

It is developing oral antiviral therapy for chronic hepatitis C (HCV) and a platform of potent and specific complement inhibitors.

  • Eye Disease
  • Monoclonal Antibody
  • Ophthalmology
  • Pharmaceutical
  • Allergan plc

About two hundred patients were randomly assigned into one of two treatment arms in a ##:## ratio.

  • Autoimmune Disease
  • Eye Disease
  • United States
  • Product Initiative
  • Galapagos NV